The latest announcement is out from Moleculin Biotech ( (MBRX) ).
Moleculin Biotech, Inc., a player in the biotech industry, recently updated its corporate presentation, which is now available on the company’s website. While this information has been shared publicly, it is not intended for official filing purposes under the Securities Exchange Act of 1934 or the Securities Act of 1933, but rather serves as an informational resource for those following the company’s progress.
Find detailed analytics on MBRX stock on TipRanks’ Stock Analysis page.
